Clinical Trial Update: Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months Old [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating immune response to fractional (one-fifth and one-half) doses of the Yellow Fever vaccine compared with full-dose in children aged 9-2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Yellow Fever

Drugs mentioned

• Yellow fever vaccine (live attenuated yellow fever vaccine)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Yellow Fever | Phase 4 | Status: COMPLETED